Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPG Blockade with Lidocaine for Episodic Migraine
NCT05210192Phase 3Unknown
- Sponsor
- Afyonkarahisar Health Sciences University
- Start
- Apr 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in episodic migraine comparing Lidocaine Arm with Placebo Arm (2 arms). Primary endpoints: Frequency of pain at 3 months, Number of attacks at 3 months and 2 more. Status: unknown.
02
Drugs
lidocaine
03
Conditions
episodic migraine
Beyond the preview
Go deeper on NCT05210192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05210192.